(Note: DD3 Acquisition Corp. III withdrew its SPAC IPO in an SEC filing dated Sept. 6, 2022. This blank check company, the third one backed by DD3 Capital Partners, filed its S-1 on March 15, 2021.) We intend to focus our search for target businesses in Mexico and Hispanic businesses in the United States. (Incorporated […]

We are a clinical and science-based company that is focused on developing and commercializing white label gel-based delivery solutions for prescription drugs, pet care, nutriceuticals and other products. (Incorporated in Australia) A “white label” gel-based delivery solution is where we produce a product that other companies rebrand as their own product. Our principal products are edible gels, which […]

(Note: CW Petroleum Corp. withdrew its plans for a NASDAQ uplisting and a public offering in a Nov. 13, 2023, letter to the SEC. The wholesale fuel distributor filed its S-1 on June 2, 2022.) (Note: This unit offering is a NASDAQ uplisting from the OTC Market. Each unit consists of one share of common […]

We are an established marine fuel logistics company providing a one-stop solution for vessel refueling, which is referred to as bunkering facilitator in the bunkering industry, in the Asia Pacific. (Incorporated in the Cayman Islands) We purchase and arrange (for) our suppliers to actually deliver marine fuel to our customers, some of which we provide […]

We are a blank check company. We intend to focus on the healthcare or healthcare-related industries. (Incorporated in the Cayman Islands) In particular, we will target North American or European companies in the life sciences and biotechnology sectors where our management has extensive investment experience. We will search for a target company in these sectors […]

(Note: Relief Therapeutics Holding SA withdrew its IPO plans in an SEC filing on Feb. 7, 2023. Relief Therapeutics filed its F-1 on Aug. 23, 2022; it not updated its prospectus since mid-November.) (Background: Relief Therapeutics Holding SA filed an F-1/A dated Nov. 15, 2022, naming H.C. Wainwright & Co. as the underwriter for its […]

We are a clinical-stage biopharmaceutical company focused on the development of the next wave of medicine for the treatment of allergic and inflammatory diseases. Our lead product candidate, THB001, is a highly selective, oral small molecule inhibitor of KIT, a cell surface receptor that acts as the master survival and functional regulator of mast cells. […]

We are a holding company with no material operations of our own. We conduct our operations in China through our variable interest entity (VIE), Taizhou Kepui Communication Equipment Co. Ltd., or Taizhou Kepuni in the People’s Republic of China (PRC). (Incorporated in the Cayman Islands) Taizhou Kepuni Communication Equipment Co., Ltd. is a high-tech enterprise integrating […]

(Note: Midwest Energy Emissions Corp. withdrew its plans for a NASDAQ uplisting from the OTC markets in an SEC filing dated Aug. 24, 2022. The company filed its S-1 for the NASDAQ uplisting/public offering on Nov. 10, 2021; no terms were filed. A reverse stock split had been planned as part of the public offering […]

(New Beginnings Acquisition Corp. II withdrew its SPAC IPO on Aug. 22, 2022. The S-1 was filed on April 7, 2021.) We intend to initially focus on companies in the travel, hospitality, leisure, financial technology (FinTech), insurance technology and property technology (PropTech) sectors in the United States. Russell W. Galbut, our chairman, has over 34 years […]